NCT00408681 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 20
- units
- Participants
- groups
- description
- Patients received oral lithium carbonate once or twice daily. Treatment continued for up to 8 weeks in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Treated Patients
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 63
- value
- 49.5
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Female
- measurements
- group Id
- BG000
- value
- 7
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 14
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Non-Hodgkin lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Acute myeloid leukemia
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Multiple myeloma
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Chronic myeloid leukemia
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Acute lymphoid leukemia
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Myelodysplastic syndrome
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Aplastic anemia
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Paroxysmal nocturnal hemoglobinuria
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Chronic lymphocytic leukemia
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Indication for transplantation
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- Myeloablative
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Nonmyeloablative
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Type of pretransplant conditioning regimen
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Cyclosporine and mycophenolate mofetil (MMF)
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- Tacrolimus and methotrexate
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Cyclophosphamide, tacrolimus, MMF
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Tacrolimus and mycophenolate mofeftil
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Graft-versus-host disease (GVHD) prophylaxis regimen
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Duodenum alone
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Colon alone
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Duodenum and colon
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Mucosal denudation
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Tacrolimus
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Cyclosporine
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Mycophenolate mofetil
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Agents given to prevent GVHD at the time of enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Infliximab
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Rabbit anti-thymocyte globulin
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Horse anti-thymocyte globulin
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Extracorporeal photopheresis
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Mesenchymal stem cells
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Mycophenolate mofetil
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Tacrolimus
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Sirolimus
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Cyclosporine
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Agents given to treat GVHD more than 3 days before enrollment in the study
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 215
- value
- 90
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Interval from transplantation to start of study product administration
- unit Of Measure
- days
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 20
- units
- Participants
- groups
- description
- Patients received oral lithium carbonate once or twice daily. Treatment continued for up to 8 weeks in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Treated Patients
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 63
- value
- 49.5
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Female
- measurements
- group Id
- BG000
- value
- 7
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 14
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Non-Hodgkin lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Acute myeloid leukemia
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Multiple myeloma
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Chronic myeloid leukemia
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Acute lymphoid leukemia
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Myelodysplastic syndrome
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Aplastic anemia
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Paroxysmal nocturnal hemoglobinuria
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Chronic lymphocytic leukemia
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Indication for transplantation
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- Myeloablative
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Nonmyeloablative
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Type of pretransplant conditioning regimen
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Cyclosporine and mycophenolate mofetil (MMF)
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- Tacrolimus and methotrexate
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Cyclophosphamide, tacrolimus, MMF
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Tacrolimus and mycophenolate mofeftil
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Graft-versus-host disease (GVHD) prophylaxis regimen
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Duodenum alone
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Colon alone
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Duodenum and colon
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Mucosal denudation
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Tacrolimus
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Cyclosporine
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Mycophenolate mofetil
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Agents given to prevent GVHD at the time of enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Infliximab
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Rabbit anti-thymocyte globulin
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Horse anti-thymocyte globulin
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Extracorporeal photopheresis
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Mesenchymal stem cells
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Mycophenolate mofetil
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Tacrolimus
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Sirolimus
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Cyclosporine
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Agents given to treat GVHD more than 3 days before enrollment in the study
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 215
- value
- 90
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Interval from transplantation to start of study product administration
- unit Of Measure
- days
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle